Skip to main content

Arda Therapeutics

San Francisco, United States

Arda is taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions.

$43.0M raised
Oct 2024
Series A

Top Investors

Andreessen HorowitzAlumni VenturesGaingelsTwo Sigma VenturesIndicator Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Arda Therapeutics

How much funding has Arda Therapeutics raised?
Arda Therapeutics has raised $43.0M in total funding. The most recent round was Series A. The last funding was announced in October 2024.
Who are Arda Therapeutics's investors?
Arda Therapeutics's investors include Andreessen Horowitz, Alumni Ventures, Gaingels, Two Sigma Ventures, Indicator Ventures.
Where is Arda Therapeutics headquartered?
Arda Therapeutics is headquartered in San Francisco, United States.
What does Arda Therapeutics do?
Arda is taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions.
What stage is Arda Therapeutics at?
Arda Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Arda Therapeutics — Funding & Investors." VCBacked, October 1, 2024, https://www.vcbacked.co/company/arda-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2024). Arda Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/arda-therapeutics
Wikipedia (cite web)
{{cite web |title=Arda Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/arda-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .